Addiction - Articles - Page 6 | CARLAT PUBLISHING

Screening and Prophylaxis of Infectious Diseases in Addiction Practice

November 22, 2019

Sandra Springer, MD

Associate Professor of Medicine in the Department of Internal Medicine, Yale School of Medicine. Director of the Infectious Disease Clinic (Newington) and Attending Infectious Disease Physician (West Haven), VA Connecticut Healthcare System.

Dr. Springer has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In this QA, we invite Dr. Sandra Springer to walk us through the various screenings for infectious diseases ranging from HIV to Hepatitis A, Hepatitis B, and Hepatitis C, as well as Tuberculosis.

PrEP: Introduction to the Basics

November 22, 2019

With the rate of new HIV infections at just under 40,000 new infections per year, it is important for addiction practitioners to be on the front lines of HIV prevention. This article and corresponding table cover the pre-exposure prophylaxis (PrEP) with Truvada.

Perioperative Management of Patients on Buprenorphine Maintenance

November 22, 2019

Gregory Acampora, MD

Gregory Acampora, MD

Psychiatrist, Pain Management Center, Massachusetts General Hospital/Harvard Center for Addiction Medicine, Boston, MA. Assistant Professor, Harvard Medical School.

Dr. Acampora has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

For patients on buprenorphine maintenance facing surgery, it is crucial to balance the need to minimize pain while addressing the risk of relapse. In this interview, Dr. Gregory Acampora guides us through the specifics on perioperatively managing patients on varying doses of buprenorphine maintenance.

Exposure Therapy Efficacious for PTSD Co-Occurring With Alcohol Use Disorder

November 22, 2019

Brian Frankel, MD

Brian Frankel, MD Dr. Frankel has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Prolonged exposure is one of the best treatments available for patients with PTSD. This study examines the advantages of using prolonged exposure for patients who have PTSD with co-occurring alcohol use disorder.

Varenicline and Bupropion: Soaring Again With EAGLES?

November 22, 2019

Nicholas Rosenlicht, MD.

Nicholas Rosenlicht, MD. Dr. Rosenlicht has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

This research update unpacks the details behind the landmark “EAGLES” trial (Evaluating Adverse Events in a Global Smoking Cessation Study), which led to the removal of the varenicline black box warning.

The COMBINE Study: A Core Paper in the Treatment of AUD

November 22, 2019

Brian Frankel, MD

Brian Frankel, MD Dr. Frankel has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

This research update summarizes the results of the landmark COMBINE study which evaluated the effectiveness of stand-alone and combined pharmacological and behavioral interventions for treating alcohol use disorder.

Growing Rate of Suicide in Teens: Assessment and Prevention

October 3, 2019

Teen suicidality is rising and child psychiatrists need support in knowing how to address suicidality in everyday practice. In this lead article we discuss office assessment, treatment, planning, and prevention for at risk children and teens. For reference we also include the Ask Suicide-Screening Questions Toolkit Questionnaire as well as a table presenting some of the evidence-based approaches for suicide screening.

Primer: Evidence-Based Psychosocial Interventions for Substance Use Disorders

October 2, 2019

Psychosocial interventions for substance use disorders include drug counseling, medical management, cognitive behavioral therapy, motivational interviewing, contingency management, the community reinforcement approach, and twelve-step facilitation

Biomarkers of Alcohol Use

October 2, 2019

The newer biomarkers of alcohol use include carbohydrate-deficient transferrin; ethyl glucuronide and ethyl sulfate; and phosphatidylethanol.

N-acetylcysteine Not Effective for Cannabis Use Disorder in Adults

October 2, 2019

Brian Frankel, MD

Brian Frankel, MD Dr. Frankel has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

N-acetylcysteine (NAC), an over-the counter supplement related to the amino acid cysteine, has been shown to have some efficacy in adolescents with cannabis use disorder (CUD). This current study explores whether NAC can be effective for CUD in adult patients as well.